SCHEMBL1099478

SCHEMBL1099478

O=C1NCCN1CCN(c1sc2ccccc2c1Br)S(=O)(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.40
KDR P35968 1/20 0.40
ALDH1A1 P00352 3/20 0.34
HTR2A P28223 4/20 0.33
KMT2A Q03164 2/20 0.33
PER2 O15055 1/20 0.32
HTR6 P50406 3/20 0.32
HTR1A P08908 2/20 0.32
DRD2 P14416 2/20 0.32
HTR7 P34969 2/20 0.32
HTR2C P28335 1/20 0.32
KDM4E B2RXH2 4/20 0.32
C1R P00736 1/20 0.31
PRSS1 P07477 1/20 0.31
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099400 0.88 RET (0.40) RETKDRALDH1A1HTR2AKMT2A
SCHEMBL1099099 0.84 ADAMTS5 (0.42) ALDH1A1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL1098240 0.82 MEN1 (0.44) ALDH1A1HTR2AKMT2AHTR6HTR1A
SCHEMBL1099720 0.81 ADAMTS5 (0.35) ALDH1A1HTR2AKMT2AHTR6HTR1A
SCHEMBL1099258 0.81 SIGMAR1 (0.45) ALDH1A1HTR2AKMT2AHTR6HTR1A
SCHEMBL1097407 0.76 KEAP1 (0.37) HTR2AHTR6HTR1ADRD2HTR7
SCHEMBL1098844 0.76 NR1I2 (0.44) ALDH1A1KMT2AKDM4EMEN1SMN1; SMN2
SCHEMBL1099694 0.76 KDM4E (0.37) ALDH1A1HTR2AKMT2AHTR2CKDM4E
SCHEMBL1099122 0.75 TRPM8 (0.37) KDM4EC1RPRSS1KEAP1NFE2L2
SCHEMBL1098503 0.75 TDP1 (0.49) KMT2AC1RPRSS1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 RET 1221/4885KDR 3861/4885ALDH1A1 3091/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 RET 1221/4885KDR 3861/4885ALDH1A1 3091/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 RET 1221/4885KDR 3861/4885ALDH1A1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.